Genpact's stock has fallen 21.6% in four weeks, indicating panic selling rather than fundamental issues. With an RSI of 26.62, it’s considered oversold, suggesting a possible price reversal. Analysts are upgrading earnings estimates, indicating potential improvements ahead, making Genpact an interesting option for investors monitoring technical and fundamental trends.